Vancomycin HCl Injection Recalled for Sterility Assurance Issues
Edge Pharma LLC is recalling Vancomycin HCl in 0.9% Sodium Chloride Injection nationwide due to lack of assurance of sterility. The affected product is a 500 mL pre-filled bag for IV injection.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Although the source text does not report specific illnesses or hospitalizations, the hazard of compromised sterility in an injectable drug represents significant potential for serious patient harm. Class II recalls by FDA policy warrant Severe (4) rating per the rubric.
Plain-English summary
Edge Pharma LLC is recalling Vancomycin HCl in 0.9% Sodium Chloride Injection, 1,500 mg/500 mL, USP, Single Use Bag for IV Injection (Preservative Free), 500 mL pre-filled bag, manufactured by Edge Pharma LLC in Colchester, VT (NDC 05446-1458-01). The recall involves 1,825 bags distributed nationwide.
The reason for the recall is lack of assurance of sterility. This is an FDA Class II recall, meaning the product may cause adverse health consequences or serious adverse effects, but is not expected to cause death.
Patients receiving this product should consult with their healthcare provider. Healthcare providers should discontinue use of the affected lots and contact their supplier or Edge Pharma LLC for instructions on return or disposal. The affected product codes are 08-2021-26@4 with date 12/08/2021 and 09-2021-21@3 with date 01/04/2022.
The recalled product
- Product
- Vancomycin HCl in 0.9% Sodium Chloride Injection, 1,500 mg/500 mL, USP, Single Use Bag for IV Injection (Preservative Free), 500 mL pre-filled bag, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1458-01
- Manufacturer
- Edge Pharma, LLC
- Category
- Drug — Injection / Injectable
- Hazard
- sterility-assurance
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 08-2021-26@4 12/08/2021 & 09-2021-21@3 01/04/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27